Sleep Hygiene: Sleep is when your body repairs tissue, produces growth hormone, and regulates hunger hormones
Moving from insulin to GLP-1 A patient on basal insulin whose Type 2 diabetes is relatively well controlled might transition to a GLP-1 agonist if they are gaining excessive weight on insulin, want to simplify their regimen, have developed cardiovascular risk factors that would benefit from GLP-1 protection, or have adequate remaining beta cell function
Researchers interested in investigating epithalons safety profile should note that the peptide has not been formally reviewed by the United States Food and Drug Administration, nor by any of its international regulatory counterparts
Ozempic | European Medicines Agency (EMA)
Never treat the numbers as interchangeable in the syringe
Fasting insulin, C-reactive protein, lipid panels, and baseline GLP-1 receptor expression patterns may provide clinical context for how dual targeting could address multiple disease pathways simultaneously in your metabolic profile